Federal Funding Opportunities, April 4-10, 2022

National Institutes of Health

RFA-AG-23-005: Health Equity and the Cost of Novel Treatments for Alzheimer’s Disease and Related Dementias (R61/R33 Clinical Trial Not Allowed) Applications Due: July 1, 2022 RFA-AG-23-003: Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed) Applications Due: July 1, 2022 RFA-AG-23-007: Screening for Cognitive Impairment: Decision-Making (U24 Clinical Trial Optional)  Applications Due: July 11, 2022 RFA-MH-22-135/136: Social Disconnection and Suicide Risk in Late Life (R01/R21 Clinical Trial Optional) Applications Due: October 15, 2022